Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|January 1, 2003
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-01-01-2003
- Volume 15
- Issue 1
Is drug delivery the enemy of drug research?
Author(s)Albedo
Brussels report
Advertisement
The European drug industry's dilemma gets no easier - drugs must be discovered before they can be delivered. However, the pharmaceutical sector's reluctance to pay for delivery still threatens to deprive the industry of the revenue to do its research.
This article is currently available in printed form only.
To ensure access to all articles from every issue of Pharmaceutical Technology Europe
Articles in this issue
over 23 years ago
Improving Dose Content Uniformity Testing for MDIs and DPIsover 23 years ago
Innovations in Pharmaceutical Packaging - Smart Blister Packsover 23 years ago
Pharmaceutical Pricing and Innovation: Key Issues in the Year AheadAdvertisement
Related to this article
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.
The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
On PharmTech.com this week, coverage of upcoming events continued, experts continued to discuss the use of AI in pharma, and validation in oral solid dosage product production was emphasized.
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
2
PharmTech’s Weekly Roundup—September 25, 2026
3
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
4
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
5